Stocks
HealthEquity Financial Statements (HQY) |
||||||||||
| HealthEquitysmart-lab.ru | % | 2024Q2 | 2024Q3 | 2024Q4 | 2024Q4 | 2025Q1 | LTM ? | |||
|---|---|---|---|---|---|---|---|---|---|---|
| Report date | 05.09.2023 | 05.12.2023 | 19.03.2024 | 22.03.2024 | 03.06.2024 | 03.06.2024 | ||||
| Currency | USD | USD | USD | USD | USD | USD | ||||
| Financial report URL | ||||||||||
| Revenue, bln rub | ? | 243.5 | 249.2 | 262.4 | 262.4 | 287.6 | 1 062 | |||
| Operating Income, bln rub | 24.7 | 30.9 | 41.2 | 41.2 | 43.8 | 157.0 | ||||
| EBITDA, bln rub | ? | 67.9 | 60.5 | 79.1 | 79.1 | 82.7 | 301.4 | |||
| Net profit, bln rub | ? | 10.6 | 14.7 | 26.4 | 26.4 | 28.8 | 96.2 | |||
| OCF, bln rub | ? | 77.1 | 57.1 | 77.1 | 77.1 | 65.4 | 276.7 | |||
| CAPEX, bln rub | ? | 10.2 | 15.4 | 8.01 | 11.3 | 270.0 | 304.7 | |||
| FCF, bln rub | ? | 66.9 | 41.7 | 69.1 | 65.8 | -204.5 | -28.0 | |||
| Dividend payout, bln rub | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | ||||
| Ordinary share dividend yield, % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | ||||
| Dividend payout ratio, % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0 | ||||
| OPEX, bln rub | 124.1 | 124.9 | 98.9 | 98.9 | 117.8 | 440.6 | ||||
| Cost of production, bln rub | 92.6 | 90.8 | 122.3 | 122.3 | 126.0 | 461.4 | ||||
| R&D, bln rub | 54.8 | 55.6 | 55.2 | 55.2 | 56.1 | 222.2 | ||||
| Interest expenses, bln rub | 13.3 | 13.5 | 13.6 | 13.6 | 11.8 | 52.6 | ||||
| Assets, bln rub | 3 066 | 3 094 | 3 164 | 3 236 | 3 246 | 3 246 | ||||
| Net Assets, bln rub | ? | 1 950 | 1 988 | 2 035 | 2 035 | 2 098 | 2 098 | |||
| Debt, bln rub | 936.0 | 934.6 | 933.1 | 933.1 | 983.7 | 983.7 | ||||
| Cash, bln rub | 290.3 | 334.1 | 404.0 | 404.0 | 251.2 | 251.2 | ||||
| Net debt, bln rub | 645.6 | 600.6 | 529.2 | 529.2 | 732.5 | 732.5 | ||||
| Ordinary share price, rub | 67.9 | 71.7 | 75.6 | 75.6 | 78.9 | 66.2 | ||||
| Number of ordinary shares, mln | 85.5 | 85.7 | 86.0 | 86.0 | 86.5 | 86.5 | ||||
| Market cap, bln rub | 5 811 | 6 143 | 6 498 | 6 498 | 6 824 | 5 725 | ||||
| EV, bln rub | ? | 6 457 | 6 743 | 7 027 | 7 027 | 7 556 | 6 458 | |||
| Book value, bln rub | -580 | -521 | -449 | -449 | -622 | -622 | ||||
| EPS, rub | ? | 0.12 | 0.17 | 0.31 | 0.31 | 0.33 | 1.11 | |||
| FCF/share, rub | 0.78 | 0.49 | 0.80 | 0.77 | -2.37 | -0.32 | ||||
| BV/share, rub | -6.79 | -6.08 | -5.22 | -5.22 | -7.19 | -7.19 | ||||
| EBITDA margin, % | ? | 27.9% | 24.3% | 30.1% | 30.1% | 28.8% | 28.4% | |||
| Net margin, % | ? | 4.34% | 5.89% | 10.0% | 10.0% | 10.0% | 9.06% | |||
| FCF yield, % | ? | 2.91% | 2.87% | 3.08% | 3.03% | -0.44% | -0.49% | |||
| ROE, % | ? | 0.66% | 1.47% | 2.74% | 2.74% | 3.83% | 4.59% | |||
| ROA, % | ? | 0.42% | 0.94% | 1.76% | 1.72% | 2.48% | 2.96% | |||
| P/E | ? | 453.1 | 210.8 | 116.6 | 116.6 | 84.8 | 59.5 | |||
| P/FCF | 34.4 | 34.9 | 32.5 | 33.0 | -226.2 | -204.7 | ||||
| P/S | ? | 6.20 | 6.33 | 6.50 | 6.50 | 6.54 | 5.39 | |||
| P/BV | ? | -10.0 | -11.8 | -14.5 | -14.5 | -11.0 | -9.21 | |||
| EV/EBITDA | ? | 26.0 | 26.4 | 25.6 | 25.6 | 26.0 | 21.4 | |||
| Debt/EBITDA | 2.60 | 2.35 | 1.92 | 1.92 | 2.52 | 2.43 | ||||
| R&D/CAPEX, % | 534.4% | 360.7% | 689.4% | 490.1% | 20.8% | 72.9% | ||||
| CAPEX/Revenue, % | 4.21% | 6.19% | 3.05% | 4.30% | 93.9% | 28.7% | ||||
| HealthEquity shareholders | ||||||||||
